Deep Breaths: Updates from CHEST

Host: Gerard A. Silvestri MD, MS, Master FCCP Guest: Anurag Singh, MD Guest: Adam H. Fox, MD, MSc Guest: Mariam Alexander, MD, PhD Recent therapeutic advances are reshaping our approach to limited-stage small cell lung cancer. In this multidisciplinary discussion, Dr. Gerard Silvestri sits down with Drs. Adam Fox, Mariam Alexander, and Anurag Singh to explore the evolving standard of care and practical considerations for timely and effective care. Dr. Silvestri is a pulmonologist and the Hillenbrand Professor of Thoracic Oncology at the Medical University of South Carolina. Dr. Fox is a pulmonologist and Assistant Professor of Medicine at the Medical University of South Carolina. Dr. Alexander is a medical oncologist and Assistant Professor of Medicine at the Medical University of South Carolina. Dr. Singh is a Professor of Radiation Oncology and the Director of Radiation Research at the Roswell Park Cancer Center in New York. This program is produced in partnership with the American College of Chest Physicians and is sponsored by AstraZeneca.

Host: Gerard A. Silvestri MD, MS, Master FCCP Guest: Anurag Singh, MD Guest: Adam H. Fox, MD, MSc Guest: Mariam Alexander, MD, PhD Despite the typically poor prognosis of extensive-stage small cell lung cancer, recent advancements are reshaping clinical perspectives on treatment. New and emerging options show promise for prolonged survival and improved quality of life. Join Drs. Gerard Silvestri, Adam Fox, Mariam Alexander, and Anurag Singh as they discuss how the therapeutic landscape is evolving for these patients. Silvestri is a pulmonologist and the Hillenbrand Professor of Thoracic Oncology at the Medical University of South Carolina. Dr. Fox is a pulmonologist and Assistant Professor of Medicine at the Medical University of South Carolina. Dr. Alexander is a medical oncologist and Assistant Professor of Medicine at the Medical University of South Carolina. Dr. Singh is a Professor of Radiation Oncology and the Director of Radiation Research at the Roswell Park Cancer Center in New York. This program is produced in partnership with the American College of Chest Physicians and is sponsored by AstraZeneca.

Host: Diego Maselli, MD Guest: Monica Kraft, MD, FCCP Guest: Anju T Peters, MD, MSCI, FAAAAI IL-5 is a key driver of Type 2 inflammation in patients with severe asthma, promoting downstream effects like mucus plugging and epithelial barrier dysfunction. Given these impacts, targeted therapy with biologics can play a role in severe asthma management. Join Drs. Diego Maselli, Anju Peters, and Monica Kraft as they explore the impacts of IL-5 and share perspectives on patient selection and shared decision-making for targeted therapies. Dr. Maselli is a Professor of Medicine at the Long School of Medicine at UT Health in San Antonio. Dr. Peters is a Professor of Medicine and Associate Chief of Clinical Research and Practice Innovation at Northwestern Medicine in Chicago. Dr. Kraft is a System Chair of the Samuel Bronfman Department of Medicine and a Professor of Medicine at the Icahn School of Medicine at Mount Sinai Health Systems in New York. This episode of Deep Breaths: Updates from CHEST was supported by a non-promotional, non-CME educational program brought to you by CHEST in collaboration with and sponsored by GSK.

Host: Nathan Falk, MD, MBA, FAAFP Guest: Megan Conroy, MD, MA(Ed), FCCP Patients with chronic obstructive pulmonary disease (COPD) often experience significant delays in diagnosis and treatment due to systemic gaps in management. A recent survey of 400 primary care and pulmonary clinicians uncovered patterns of fragmented care among both specialties. Join Dr. Nate Falk and Dr. Megan Conroy as they dive into the findings and explain how CHEST's COPD Toolkit can help clinicians address these gaps and provide a coordinated approach to COPD management. Dr. Falk is a board-certified family physician as well as a Professor and Founding Residency Director for Family Medicine at Florida State University in partnership with BayCare Health System. Dr. Conroy is a Chair and Assistant Professor in the Division of Pulmonary, Critical Care, and Sleep Medicine at The Ohio State University. This program is produced in partnership with the American College of CHEST Physicians and is supported by Regeneron Pharmaceuticals, Inc.

Host: Nathan Falk, MD, MBA, FAAFP Guest: Ashwin Basavaraj, MD Early recognition and diagnosis of non-tuberculosis mycobacteria (NTM) and bronchiectasis are key for optimal patient management. However, these conditions are often misdiagnosed as COPD or asthma, leading to significant challenges and delays in treatment. Join Drs. Nate Falk and Ashwin Basavaraj as they share perspectives on accurately diagnosing NTM and bronchiectasis with early symptom recognition, a thorough patient history, and testing. Dr. Falk is a board-certified family medicine physician, a Professor and Founding Residency Director for Family Medicine at Florida State University in partnership with BayCare Health System, and the Assistant Dean for Graduate Medical Education at Florida State University. Dr. Basavaraj is an Associate Professor of Medicine at New York University Grossman School of Medicine, the Director of the Bronchiectasis and NTM Education Program at NYU Langone Health, and the Section Chief of Pulmonary, Critical Care, and Sleep Medicine at Bellevue Hospital Center. This program is produced in partnership with the American College of CHEST Physicians and is sponsored by Insmed Incorporated.

Guest: Ashwin Basavaraj, MD Guest: Keren Bakal, MD Guest: Nathan Falk, MD, MBA, FAAFP Guest: Amy Springer, NP Often mistaken for COPD or asthma, bronchiectasis and nontuberculous mycobacteria (NTM) can be difficult to recognize and test for, often delaying diagnosis and effective treatment. However, an emphasis on education and research can help address these diagnostic gaps, and involving a multidisciplinary care team can improve treatment plans and patient outcomes. Joining Dr. Ashwin Basavaraj, Associate Professor of Medicine at NYU Grossman School of Medicine, to talk about how we can optimize the diagnosis and management of bronchiectasis and NTM are Dr. Keren Bakal, Dr. Nathan Falk, and Ms. Amy Springer. Dr. Bakal is a pulmonologist specializing in critical care medicine at Overlook Medical Center and Morristown Medical Center in New Jersey, Dr. Falk is a Professor and the founding Residency Director for Family Medicine at Florida State University, and Ms. Springer is a Senior Nurse Practitioner at NYU Langone Health. This program is produced in partnership with the American College of CHEST Physicians, and is sponsored by Insmed Incorporated.

Host: Isaretta Riley, MD, MPH Guest: Nicola A. Hanania, MD, MS, FCCP Guest: Jay Peters, MD A recent study assessing the impact of implicit bias on uncontrolled asthma treatment found that a patient's identity and socioeconomic status can unintentionally influence a physician's decision-making, impacting the quality of care. Additionally, a critical gap exists in clinician awareness and implementation of health equity practices, which play a key role in mitigating these unintended consequences. That's why Drs. Isaretta Riley, Nicola Hanania, and Jay Peters come together to explore the latest research on unconscious bias in asthma treatment and provide recommendations for more equitable care. Dr. Riley is an Assistant Professor of Medicine at Duke University School of Medicine in Durham, North Carolina; Dr. Hanania is a Professor of Pulmonary Medicine and the Director of Airways Clinical Research Center at Baylor College of Medicine in Houston, Texas; and Dr. Peters is a Professor Emeritus of Medicine in the Division of Pulmonary Diseases and Critical Care Medicine at the University of Texas, San Antonio. This episode of Deep Breaths: Updates from CHEST was supported by a non-promotional, non-CME educational program brought to you by CHEST in collaboration with and sponsored by GSK.

Host: Megan Conroy, MD, MA(Ed), FCCP Guest: Nathan Falk, MD, MBA, FAAFP Primary care providers can play a pivotal role in a patient's COPD diagnosis by looking out for signs and symptoms and referring patients to pulmonologists when appropriate. The goal of this activity is to educate clinicians about managing patients with COPD symptoms and facilitating earlier diagnosis. Hear both primary care and pulmonary perspectives on diagnostic strategies. CLINICIANS: To access additional resources for COPD diagnosis, visit chestnet.org/timely- diagnosis-COPD or scan the QR code.

Guest: Ryan Maves, MD Guest: Susan Corbridge, PhD, APRN, ACNP-BC, FAANP, FCCP, FAAN Although there have been several advances in vaccine technology and safety the past few years, the prevalence of vaccine hesitancy among patients is increasing. Since vaccine hesitancy heightens the burden of potentially life-threatening viruses like RSV and influenza, Dr. Ryan Maves speaks with Dr. Susan Corbridge about why patients might be reluctant to get vaccinated and how we can use the First 5 Minutes approach to provide individualized counseling on the importance of vaccines. Dr. Maves is a Professor of Medicine and Anesthesiology in the Sections of Infectious Diseases and Critical Care Medicine at the Wake Forest University School of Medicine, and Dr. Corbridge is a Professor Emerita at the University of Illinois at Chicago College of Nursing. This episode is supported by an educational grant from Moderna.

Host: Angela Birdwell, DO, MA, FCCP Guest: Antonio Anzueto, MD Guest: Susan Corbridge, PhD, APRN, ACNP-BC, FAANP, FCCP, FAAN Although the prevalence of chronic obstructive pulmonary disease (COPD) has decreased in adults aged 18 to 44, it remains elevated in certain patient groups, like women, adults over 65, smokers, and those living in rural areas. This prevalence emphasizes the importance of a patient-centered approach, which is why Dr. Angela Birdwell speaks with Drs. Antonio Anzueto and Susan Corbridge about how open conversations and the First 5 Minutes concept can help personalize the care of COPD patients and lead to better outcomes. Dr. Anzueto is a Professor of Medicine at the South Texas Veterans Health Care System and UT Health San Antonio, and Dr. Corbridge is the Chief Essentials Program Officer at the American Association of Colleges of Nursing and a Professor Emerita at the University of Illinois at Chicago College of Nursing. This non-CME education is brought to you by CHEST, and this program is supported by Regeneron Phamraceuticals, Inc. and Sanofi.

Host: Farrukh Abbas, MD Guest: Megan Conroy, MD, MA(Ed) Listen in as Farrukh Abbas, MD, FCCP, and Megan Conroy, MD, MAEd, FCCP, discuss the role of the care team in COPD diagnosis, recent changes in classifications and updates to the GOLD guidelines, how triple-inhaler therapies and biologics can be used to treat patients with COPD, and more. Since the time of this recording, the FDA has recently approved dupilumab as an add-on maintenance treatment for adult patients with inadequately controlled chronic obstructive pulmonary disease (COPD) with type 2 inflammation.

Host: Tom Corbridge, MD, FCCP Guest: De De Gardner, DrPH, RRT, RRT-NPS, FAARC, FCCP Guest: Diego Maselli, MD Guest: Praveen Akuthota, MD As we continue to learn more about the underlying inflammatory pathways in asthma, we now have more novel tools and treatments to help us achieve control, remission, and better outcomes for our patients. But in order to achieve those goals, we must first detect severe asthma early enough to take full advantage of the latest advancements. Learn more about the importance of early detection and intervention in severe asthma care through the lens of a real-world patient case with Drs. Tom Corbridge, De De Gardner, Diego Maselli, and Praveen Akuthota. This is a non-promotional, non-CME disease state disease education podcast series brought to you by American College of CHEST Physicians in collaboration with and paid for by GSK.

Host: Demondes Haynes, MD Guest: Njira Lugogo, MD Guest: Neil Skolnik, MD According to data from the CDC, over half of patients in the United States are not considered well controlled, and there hasn't been much improvement in exacerbations as measured by ER visits or by deaths per year in the last 30 years or so. But fortunately, the use of single maintenance and reliever therapy (SMART) has been shown to help address inflammation and decrease exacerbations. Drs. Demondes Haynes, Njira Lugogo, and Neil Skolnik discuss this approach and other combination treatment for asthma. This non-CME education is brought to you by CHEST and is sponsored by AstraZeneca.

Host: Demondes Haynes, MD Guest: Njira Lugogo, MD Guest: Neil Skolnik, MD When it comes to managing acute asthma symptoms and reducing risk for patients, our focus is now on relieving bronchoconstriction and inflammation. Given this fundamental change, it's important to ensure that our patients understand this shift. Find out how taking a shared decision-making approach can help patients embrace this change in addition to improving their adherence and outcomes with Drs. Demondes Haynes, Njira Lugogo, and Neil Skolnik. This non-CME education is brought to you by CHEST and is sponsored by AstraZeneca.

Host: Demondes Haynes, MD Guest: Njira Lugogo, MD Guest: Neil Skolnik, MD Expert opinions from NAEPP and GINA recommend treating both symptoms and inflammation in asthma patients concomitantly. Joining Dr. Demondes Haynes to talk about these updates and therapies for asthma like short-acting beta agonists and inhaled corticosteroids are Drs. Njira Lugogo and Neil Skolnik. This non-CME education is brought to you by CHEST and is sponsored by AstraZeneca.

Guest: Stephen Doyle, DO, MBA, FCCP Guest: Navitha Ramesh, MD, FCCP Host: Sandhya Khurana, MD, FCCP The goal of this activity is to use case-based learning to highlight the importance of targeting TSLP in the three types of severe asthma to raise awareness about optimal available treatments and best-practices for designing treatment plans to ultimately improve patient outcomes

Guest: Sandhya Khurana, MD, FCCP Guest: Navitha Ramesh, MD Guest: Stephen Doyle, DO, MBA, FCCP The goal of this activity is to use case-based learning to highlight the importance of targeting TSLP in the three types of severe asthma to raise awareness about optimal available treatments and best-practices for designing treatment plans to ultimately improve patient outcomes.

Host: Ryan Maves, MD Guest: Kelly Pennington, MD It's estimated that respiratory syncytial virus (RSV) is responsible for up to 30 percent of viral respiratory infections in the stem cell transplant population. So how can we help RSV patients achieve their best outcomes? Learn more with Dr. Ryan Maves as he speaks with Dr. Kelly Pennington, Assistant Professor of Medicine at the Mayo Clinic in Rochester, Minnesota. This program is produced in partnership with the American College of CHEST Physicians and is supported by an educational grant from GSK.

Host: Ryan Maves, MD Guest: Megan Conroy, MD, MA(Ed) Respiratory syncytial virus (RSV) is most commonly recognized for the significant disease it causes in infants and young children. However, over time its prevalence in adults has increased. Tune in to learn more with Dr. Ryan Maves as he speaks with Dr. Megan Conroy, Assistant Professor of Medicine at the Ohio State University in Columbus. This program is produced in partnership with the American College of CHEST Physicians and is supported by an educational grant from GSK.

Host: Ashwin Basavaraj, MD Guest: Christopher Lippincott, MD, MPH Bronchiectasis is a complex syndrome that can lead to an interconnected cascade of airway dysfunction and inflammation. How has our understanding of this syndrome evolved with Cole's vicious cycle hypothesis? Dr. Ashwin Basavaraj and Dr. Christopher Lippincott take a closer look at this hypothesis and the clinical mechanisms behind bronchiectasis. This program is produced in partnership with the American College of CHEST Physicians, and is sponsored by Insmed Incorporated.

Guest: Ashwin Basavaraj, MD Host: Christopher Lippincott, MD, MPH From airway clearance techniques and mucoactive therapy—what can clinicians do to manage bronchiectasis exacerbations? To answer this question, Dr. Christopher Lippincott and Dr. Ashwin Basavaraj explore the mechanisms that lead to bronchiectasis and share strategies to manage exacerbations. This program is produced in partnership with the American College of CHEST Physicians, and is sponsored by Insmed Incorporated.

Host: Navitha Ramesh, MD, FCCP Guest: Allen Blaivas, DO, FCCP When selecting the right delivery device for your patient with COPD, there are a lot of factors to consider. To help us better understand these key components, Dr. Navitha Ramesh and Dr. Allen Blaivas from the Rutgers New Jersey Medical School discuss nebulizer therapy, delivery devices, and patient education. This is a non-promotional, non-CME disease state educational program brought to you by CHEST. Sponsored by Theravance BioPharma and Viatris.

Host: Stephanie Christenson, MD Guest: Ron Balkissoon, MD, MSc, DIH, FRCPC What do we need to know about the pathophysiology and burden of COPD exacerbations? To better understand this—and the factors that may put our patients at risk—Dr. Stephanie Christenson from the University of California San Francisco and Dr. Ron Balkissoon from National Jewish Health share insights on COPD exacerbations. This is a non-promotional, non-CME disease state educational program brought to you by CHEST in collaboration with and sponsored by GSK.

Host: Stephanie Christenson, MD Guest: Ron Balkissoon, MD, MSc, DIH, FRCPC What is a COPD exacerbation, and what puts our patients at risk of them? Drs. Stephanie Christenson and Ron Balkissoon discuss these risks and the burden of COPD exacerbations on our patients. This is a non-promotional, non-CME disease state educational program brought to you by CHEST in collaboration with and sponsored by GSK.

Host: Randy Young, MD Guest: Tufik Assad, MD, MSCI What are the factors that make diagnosing pneumonia challenging, and how might emerging testing modalities improve that? To answer this question, Dr. Randy Young and Dr. Tufik Assad from the Williamson Medical Center in Franklin, Tennessee dive into the etiology, diagnostic challenges, and current trends in pneumonia diagnostics. This is a non-promotional, non-CME disease state educational podcast produced in partnership with the American College of Chest Physicians and is supported by bioMèrieux.

Host: Randy Young, MD Guest: Daniel Jay Feinstein, MD, FACP, MS, ACRP-PI Diagnosing pneumonia can be challenging, but the CAP guidelines offer recommendations to improve the detection of this infection. To find out more about the recommendations, Dr. Randy Young and Dr. Daniel Feinstein, a Physician Executive at Novant Health, dive into testing for pneumonia. This is a non-promotional, non-CME disease state educational podcast produced in partnership with the American College of Chest Physicians and is supported by bioMèrieux.

Host: David Schulman, MD, MPH, FCCP Guest: William Lago, MD Guest: Tejaswini Kulkarni, MD, MPH, FCCP What are some of the barriers to early diagnosis for idiopathic pulmonary fibrosis (IPF)? Joining Dr. David Schulman to share their perspectives on the latest diagnostic challenges and provide strategies to combat them are Drs. Tejaswini Kulkarni and William Lago. This is a non-promotional, non-CME disease state educational podcast produced in partnership with the American College of Chest Physicians and is supported by Three Lakes Foundation.

Host: Frank C. Sciurba, MD, FCCP Guest: Emily L. Yee, MD What do we need to know about using endobronchial valves in patients with severe COPD and emphysema? Drs. Frank Sciurba and Emily Yee explore the impact of these valves on patients. This educational podcast is produced in partnership with the American College of CHEST Physicians and sponsored by Pulmonx Corporation, the manufacturer of Zephyr. Click here to find additional educational resources for clinicians and patients.

Host: Doreen Addrizzo-Harris, MD Guest: Ashwin Basavaraj, MD From evaluating diagnostic criteria to nonpharmacologic therapy, what do the NTM guidelines recommend when it comes to the treatment of MAC lung disease? Drs. Doreen Addrizzo-Harris and Ashwin Basavaraj from NYU Grossman School of Medicine will dive into the practical application of the NTM guidelines. This program is produced in partnership with the American College of CHEST Physicians, and is sponsored by Insmed Incorporated.

Host: Ashwin Basavaraj, MD Nontuberculous mycobacteria (NTM) and bronchiectasis are challenging diseases that require a multidisciplinary approach to treat. Dr. Ashwin Basavaraj sits down with his patient, Mary, to learn more about these obstacles and discuss how we can find the right care team. This program is produced in partnership with the American College of CHEST Physicians, and is sponsored by Insmed Incorporated.

Host: Septimiu Murgu, MD, FCCP Host: Eric Edell, MD, FCCP Guest: Narjust Duma, MD Guest: Janani Reisenauer, MD Guest: Colleen Channick, MD, FCCP, DAABIP A multidisciplinary panel including a medical oncologist, a thoracic surgeon, and an interventional pulmonologist will discuss the role of lung cancer teams in their thoracic oncology practices. The panelists will review their management of patients with lung cancer during the COVID-19 pandemic, including the impact of delayed procedures and telemedicine on patient outcomes.

Host: Septimiu Murgu, MD, FCCP Host: Eric Edell, MD, FCCP Guest: Narjust Duma, MD Guest: Andreas Rimner, MD Two internationally known medical and radiation oncologists will discuss ongoing and recent clinical trials and offer their perspectives on how they will impact thoracic oncology practice. The panelists will also discuss current guidelines for managing patients with advanced lung cancer and emphasize the role of tissue and blood biomarkers.

Host: Eric Edell, MD, FCCP Host: Septimiu Murgu, MD, FCCP Guest: Narjust Duma, MD Guest: Christopher Hartley, MD Guest: Jeffrey Mueller, DO Expert pathologists and a medical oncologist will discuss current guidelines and their own practices regarding the role of liquid biopsy and comprehensive genetic and PD-L1 testing in the management of advanced lung cancer. The panelists will also explore various strategies for optimizing the quantity and quality of cytology and small volume biopsy specimens.

Host: Septimiu Murgu, MD, FCCP Host: Eric Edell, MD, FCCP Guest: Nichole Tanner, MD, MS, FCCP Guest: Fabien Maldonado, MD, FCCP Two internationally known interventional pulmonologists will discuss current guidelines and their own experiences regarding sampling of lung lesions and mediastinal adenopathy. Specifically, the panelists will discuss the pros and cons of various diagnostic strategies and sampling techniques, including transcutaneous and bronchoscopic biopsies. This interactive webinar will offer the opportunity for learners to ask questions prior to and during the event. Learning is augmented by a few follow-up quizzes weeks after the webinar, a strategy proven to improve knowledge gain and retention.

Host: David Schulman, MD, MPH, FCCP Guest: Andrew H. Limper, MD Guest: Timothy A. Hernandez, MD There are many barriers to reaching a definitive diagnosis for idiopathic pulmonary fibrosis (IPF). To learn more about these obstacles—and how we can overcome them—Dr. David Schulman from the American College of Chest Physicians joins Dr. Tim Hernandez from the University of Texas Health Sciences Center and Dr. Andrew Limper from the Mayo Clinic to discuss the diagnosis of IPF. This is a non-promotional, non-CME disease state educational podcast produced in partnership with the American College of Chest Physicians and is supported by Three Lakes Foundation. https://info.chestnet.org/bridging-specialties-timely-diagnosis-for-ild-patients

Host: Peter Howarth BSc, (Hons), MBBS, DM, FRCP Guest: Kathleen M. Buchheit, MD Guest: Philippe Gevaert, MD, PhD Do cytokines play a role in chronic rhinosinusitis? Dr. Peter Howarth is joined by Dr. Katie Buchheit, an Associate Professor of Medicine at Harvard Medical School, and Professor Philippe Gevaert, an ENT specialist at the Department of Otorhinolaryngology at Ghent University and the Upper Airway Research Laboratory, to explore the role of inflammatory mediators in the progression of chronic rhinosinusitis with nasal polyps. This is a nonpromotional, non-CME disease state educational podcast brought to you by the American College of CHEST Physicians in collaboration with and paid for by GSK.

Guest: Peter Howarth BSc, (Hons), MBBS, DM, FRCP Guest: Ian Pavord, MA, DM, FRCP, FERS, FMedSci Guest: Geoffrey Chupp, MD Type 2 inflammation can be challenging to identify. What should we be looking for in our patients with severe asthma and COPD? Joining Dr. Peter Howarth to discuss identifying this type of inflammation are Dr. Geoffrey Chupp from the Yale School of Medicine and Dr. Ian Pavord from the University of Oxford. This is a nonpromotional, non-CME disease state educational podcast brought to you by the American College of CHEST Physicians in collaboration with and paid for by GSK.

Host: Muhammad Adrish MD, MBA, FCCP, FCCM Guest: Navitha Ramesh, MD, FCCP Inhalers are one of the most common methods of delivery for the treatment of COPD, but is it the best option for all of our patients? Associate Professor of Pulmonary Critical Care at Baylor College of Medicine, Dr. Muhammad Adrish, reviews LAMA use for COPD patients with Dr. Navitha Ramesh, Assistant Professor at Drexel University College of Medicine. This episode is produced in partnership with the American College of CHEST Physicians and is sponsored by Viatris Inc.

Host: Megan Conroy, MD, MA(Ed) Guest: Farrukh Abbas, MD On average, more than two-thirds of patients with chronic obstructive pulmonary disease (COPD) make at least one error in using an inhaler device. Fortunately, nebulized long-acting muscarinic antagonists (LAMAs) can help our patients overcome this common challenge in COPD care. That's why Drs. Megan Conroy and Farrukh Abbas come together to talk about the GOLD treatment guidelines, strategies for reducing patient hesitancy regarding nebulized LAMAs, and more. This episode is produced in partnership with the American College of CHEST Physicians and is sponsored by Viatris Inc.

Host: Tom Corbridge, MD, FCCP Guest: Michael E. Wechsler, MD, MMSc Severe asthma is an uncontrolled disease that can be difficult to diagnose. To help us overcome this obstacle, Dr. Tom Corbridge joins Dr. Michael Wechsler from National Jewish Health in Denver to discuss the challenges we face while trying to diagnose severe asthma. This is a non-promotional, non-CME disease state disease education podcast series brought to you by American College of CHEST Physicians in collaboration with and paid for by GSK.

Guest: Jared Nathan Silver, MD, PhD Guest: Praveen Akuthota, MD Eosinophilic granulomatosis with polyangiitis and hypereosinophilic syndromes are often mistaken for each other. How can we better distinguish these diseases? Dr. Jared Silver discusses how to diagnose these diseases with Dr. Praveen Akuthota, a pulmonologist from U.C. San Diego Medical Center in California. This is a non-promotional, non-CME disease state disease education podcast series brought to you by American College of CHEST Physicians in collaboration with and paid for by GSK.

Host: Lisa K Moores, MD, FCCP, MACP Guest: David Jiménez MD, PhD, FERS Guest: Geert-Jan Geersing MD, PhD Physicians are challenged in adopting the latest clinical guidelines and integrating new and existing treatment advances into practice when managing patients with VTE.